Allurion Technologies, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Allurion Technologies, Inc. (ALUR) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$4.39 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-05-15
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was -$4.39M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was -$3.25M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was -$1.42M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-06-30 was -$2.10M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$12.43M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was -$11.48M.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was -$548.00K, a 166.75% decline from fiscal 2022.
- Allurion Technologies, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $821.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$4.39M 10-Q · filed 2026-05-15 | -$7.64M derived: sum of 2 quarters · filed 2026-05-15 | -$9.07M derived: sum of 3 quarters · filed 2026-05-15 | -$11.16M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | -$3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$4.68M derived: sum of 2 quarters · filed 2026-03-30 | -$6.77M derived: sum of 3 quarters · filed 2026-03-30 | -$12.43M 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$1.42M 10-Q · filed 2025-11-17 | -$3.52M derived: sum of 2 quarters · filed 2025-11-17 | -$9.17M 10-Q · filed 2025-11-17 | -$11.85M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-06-30 | -$2.10M 10-Q · filed 2025-08-19 | -$7.75M 10-Q · filed 2025-08-19 | -$10.43M derived: sum of 3 quarters · filed 2026-05-15 | -$18.55M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-03-31 | -$5.66M 10-Q · filed 2026-05-15 | -$8.34M derived: sum of 2 quarters · filed 2026-05-15 | -$16.46M derived: sum of 3 quarters · filed 2026-05-15 | -$16.61M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$10.80M derived: sum of 2 quarters · filed 2026-03-30 | -$10.96M derived: sum of 3 quarters · filed 2026-03-30 | -$11.48M 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$8.12M 10-Q · filed 2025-11-17 | -$8.28M derived: sum of 2 quarters · filed 2025-11-17 | -$8.80M 10-Q · filed 2025-11-17 | -$8.90M derived: sum of 4 quarters · filed 2025-11-17 | |
| 2024-06-30 | -$159.00K 10-Q/A · filed 2025-08-28 | -$676.00K 10-Q/A · filed 2025-08-28 | -$777.00K derived: sum of 3 quarters · filed 2025-08-28 | -$2.90M derived: sum of 4 quarters · filed 2025-08-28 | |
| 2024-03-31 | -$517.00K 10-Q/A · filed 2025-08-28 | -$618.00K derived: sum of 2 quarters · filed 2025-08-28 | -$2.74M derived: sum of 3 quarters · filed 2025-08-28 | -$2.54M derived: sum of 4 quarters · filed 2025-08-28 | |
| 2023-12-31 | -$101.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$2.23M derived: sum of 2 quarters · filed 2025-08-28 | -$2.02M derived: sum of 3 quarters · filed 2025-08-28 | -$548.00K 10-K/A · filed 2025-08-28 | |
| 2023-09-30 | -$2.13M 10-Q/A · filed 2025-08-28 | -$1.92M derived: sum of 2 quarters · filed 2025-08-28 | -$447.00K 10-Q/A · filed 2025-08-28 | $475.00K derived: sum of 4 quarters · filed 2025-08-28 | |
| 2023-06-30 | $204.00K 10-Q/A · filed 2025-08-28 | $2.05M 10-Q · filed 2023-10-20 | $1.68M 10-Q/A · filed 2025-08-28 | $2.60M derived: sum of 3 quarters · filed 2025-08-28 | $2.53M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $1.48M 10-Q/A · filed 2025-08-28 | -$1.50M 10-Q · filed 2023-10-20 | $2.40M derived: sum of 2 quarters · filed 2025-08-28 | $2.33M derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | $922.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $855.00K derived: sum of 2 quarters · filed 2025-08-28 | $821.00K 10-K/A · filed 2025-08-28 | ||
| 2022-09-30 | -$67.00K 10-Q · filed 2023-11-14 | -$101.00K 10-Q · filed 2023-11-14 | |||
| 2022-03-31 | $34.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |